Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Quick Notes: Device Approvals — Jan. 12, 2024

  • Post author:PacConAdmin
  • Post published:January 12, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

This edition of Quick Notes includes coverage of a cloth vest/halter that continuously monitors blood pressure, a Mayo Clinic deal on a newly cleared breast tumor 3D modeling device, and…

Continue ReadingQuick Notes: Device Approvals — Jan. 12, 2024

FDA Labels Recalls of ResMed Masks, Busse Sterile Trays, Fresenius Infusion Pumps

  • Post author:PacConAdmin
  • Post published:January 12, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

The FDA has classified three recalls as Class I because use of the devices carries the potential of serious adverse health effects and death. Source: Drug Industry Daily

Continue ReadingFDA Labels Recalls of ResMed Masks, Busse Sterile Trays, Fresenius Infusion Pumps

FDA Sees No Evidence of Suicidal Ideation in Diabetes/Diet Drugs

  • Post author:PacConAdmin
  • Post published:January 12, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

After evaluating reports of suicidal thoughts or action in patients taking diabetes and weight loss drugs containing glucagon-like peptide 1 receptor agonists (GLP-1 RA) such as Ozempic/Wegovy, Byetta, Trulicity and…

Continue ReadingFDA Sees No Evidence of Suicidal Ideation in Diabetes/Diet Drugs

Regulatory Update — Week of Jan. 8, 2024

  • Post author:PacConAdmin
  • Post published:January 12, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

Over the past week, the FDA issued a final guidance viral safety evaluation of biotechnology product derived from human or animal cells and draft guidance on sterility information in 510(k)…

Continue ReadingRegulatory Update — Week of Jan. 8, 2024

UK Regulatory Agency Announces Roadmap for New Medical Technology Regulations

  • Post author:PacConAdmin
  • Post published:January 12, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has laid out the final roadmap for 2024 to create a comprehensive set of regulations for medical devices and technology, bringing…

Continue ReadingUK Regulatory Agency Announces Roadmap for New Medical Technology Regulations

FDA Allows Importation of Penicillin From France to Address Syphilis Drug Shortage

  • Post author:PacConAdmin
  • Post published:January 11, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

To address the ongoing U.S. shortages of Bicillin L-A, a drug used to treat syphilis, the FDA has temporarily approved French manufacturer Laboratoires Delbert to import 3.6 million units of…

Continue ReadingFDA Allows Importation of Penicillin From France to Address Syphilis Drug Shortage

Two Guidances Focus on ANDA Reconsideration and Viral Safety of Biotech Products

  • Post author:PacConAdmin
  • Post published:January 11, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

In two recently issued documents, the FDA tackled methods for requesting reconsideration of an ANDA decision and provided final guidance on evaluating the viral safety of biotechnology products. Source: Drug…

Continue ReadingTwo Guidances Focus on ANDA Reconsideration and Viral Safety of Biotech Products

Califf Signals Desire for Adaptive Algorithms, Capable of Change, in Medical Devices

  • Post author:PacConAdmin
  • Post published:January 11, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

FDA Commissioner Robert Califf wants to push the agency toward approving AI assisted medical devices that contain algorithms capable of learning, adapting and changing as they gather and analyze more…

Continue ReadingCaliff Signals Desire for Adaptive Algorithms, Capable of Change, in Medical Devices

FDA Highlights EtO Transition Challenges During Device Sterilization Town Hall

  • Post author:PacConAdmin
  • Post published:January 11, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

During a virtual town hall Wednesday, FDA staff divulged there are currently no fully adequate substitutes for ethylene oxide (EtO), a chemical used to sterilize half of all medical devices…

Continue ReadingFDA Highlights EtO Transition Challenges During Device Sterilization Town Hall

Fraudulent ‘Zombie’ Trials Live on in Literature, Impacting Future Research

  • Post author:PacConAdmin
  • Post published:January 10, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

There’s been a rising concern with clinical trial fraud and misconduct, particularly over the number of “zombie” trials that have been discovered in recent years — that is, trials in…

Continue ReadingFraudulent ‘Zombie’ Trials Live on in Literature, Impacting Future Research
  • Go to the previous page
  • 1
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 144
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.